SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FDC - Quaterly Results

12 Feb 2025 Evaluate
The Total revenue for the quarter ended December 2024 of  Rs. 4588.62 millions remain, more or less, the same.Net Profit of the company move down -53.50% to Rs. 364.48  millions from Rs. 783.76 millions  in the same quarter last year.Operating profit for the quarter ended December 2024 decreased to 645.90 millions as compared to 1072.32 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 4588.62 4522.15 1.47 15881.07 14619.53 8.63 19161.87 17770.32 7.83
Other Income 186.45 253.31 -26.39 814.76 825.00 -1.24 1032.16 539.12 91.45
PBIDT 645.90 1072.32 -39.77 3415.14 3631.17 -5.95 4416.74 3084.87 43.17
Interest 9.44 9.67 -2.38 33.07 30.56 8.21 40.00 40.39 -0.97
PBDT 636.46 1062.65 -40.11 3382.07 3600.61 -6.07 4376.74 3044.48 43.76
Depreciation 133.24 99.33 34.14 380.77 293.34 29.81 397.29 387.58 2.51
PBT 503.22 963.32 -47.76 3001.30 3307.27 -9.25 3979.45 2656.90 49.78
TAX 138.74 179.56 -22.73 747.20 717.59 4.13 907.82 647.25 40.26
Deferred Tax 4.64 -24.44 -118.99 53.10 -6.60 -904.55 51.63 -42.75 -220.77
PAT 364.48 783.76 -53.50 2254.10 2589.68 -12.96 3071.63 2009.65 52.84
Equity 162.81 162.81 0.00 162.81 165.91 -1.87 162.81 165.91 -1.87
PBIDTM(%) 14.08 23.71 -40.64 21.50 24.84 -13.42 23.05 17.36 32.78

FDC Share Price

358.65 2.60 (0.73%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×